LYFE Capital is a Shanghai-based venture capital firm founded in 2015, specializing in early-stage investments within the healthcare sector, including biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, and digital health. The firm focuses on companies with established products seeking capital to accelerate growth, particularly in Greater China. Beyond financial support, LYFE Capital offers market planning, talent acquisition, global expansion, and partnership assistance to its portfolio companies.

As of 2025, LYFE Capital has made 146 investments and achieved 22 successful exits.